Cargando…

Bringing Advanced Therapies for Parkinson’s Disease to the Clinic: The Scientist’s Perspective

After many years of preclinical development, cell and gene therapies have advanced from research tools in the lab to clinical-grade products for patients, and today they constitute more than a quarter of all new Phase I clinical trials for Parkinson’s disease. Whereas efficacy has been convincingly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomishima, Mark, Kirkeby, Agnete
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543246/ https://www.ncbi.nlm.nih.gov/pubmed/34250954 http://dx.doi.org/10.3233/JPD-212685

Ejemplares similares

Bringing Advanced Therapies for Parkinson’s Disease to the Clinic: The Patient’s Perspective
por: Mathur, Soania, et al.
Publicado: (2021)

Bringing Advanced Therapy Medicinal Products (ATMPs) for Parkinson’s Disease to the Clinic: The Investigator’s Perspective
por: Barker, Roger A., et al.
Publicado: (2021)

Bringing Neural Cell Therapies to the Clinic: Past and Future Strategies
por: Irion, Stefan, et al.
Publicado: (2016)

Bringing Advanced Therapies for Parkinson’s Disease to the Clinic: An Analysis of Ethical Issues
por: Hug, Kristina
Publicado: (2021)

Are Stem Cell-Based Therapies for Parkinson’s Disease Ready for the Clinic in 2016?
por: Barker, Roger A., et al.
Publicado: (2016)

Current advancements of modelling schizophrenia using patient-derived induced pluripotent stem cells
por: Dubonyte, Ugne, et al.
Publicado: (2022)

Photo Animation Brings Scientists Back to Life in the Classroom
por: Goudsouzian, Lara K.
Publicado: (2017)

Scientists Collider in Europe won't bring end of the Earth
Publicado: (2008)

How can scientists bring research to use: the HENVINET experience
por: Bartonova, Alena
Publicado: (2012)

The case of philanthropy: bringing scientists and philanthropic donors together, for good
por: Flatto, Olivia Tournay
Publicado: (2015)

Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson’s Disease
por: Kirkeby, Agnete, et al.
Publicado: (2017)

Bringing New PET Drugs to Clinical Practice - A Regulatory Perspective
por: Hung, Joseph C.
Publicado: (2013)

Can cinnamon bring aroma in Parkinson's disease treatment?
por: Pahan, Priyanka, et al.
Publicado: (2015)

Synaptojanin 1 Mutation in Parkinson's Disease Brings Further Insight into the Neuropathological Mechanisms
por: Drouet, Valérie, et al.
Publicado: (2014)

Bringing the heavy: carbon ion therapy in the radiobiological and clinical context
por: Schlaff, Cody D, et al.
Publicado: (2014)

Recent advances and perspectives of metabolomics-based investigations in Parkinson’s disease
por: Shao, Yaping, et al.
Publicado: (2019)

Why scientists, academic institutions, and investors fail in bringing more products to the bedside: the Active Compass model for overcoming the innovation paradox
por: Ilan, Yaron
Publicado: (2021)

Bringing a genomic perspective to the safety of drug treatment in oncology
por: Innocenti, Federico
Publicado: (2017)

Bringing New Methods to the Seed Proteomics Platform: Challenges and Perspectives
por: Smolikova, Galina, et al.
Publicado: (2020)

Bringing Nitric Oxide to the Molybdenum World—A Personal Perspective
por: Maia, Luisa B.
Publicado: (2023)

Generating regionalized neuronal cells from pluripotency, a step-by-step protocol
por: Kirkeby, Agnete, et al.
Publicado: (2013)

Bringing the clinical laboratory into the strategy to advance diagnostic excellence
por: Lubin, Ira M., et al.
Publicado: (2021)

Dopamine Agonist Therapy in Advanced Parkinson’s Disease
por: Reichmann, Heinz
Publicado: (2009)

Recent Advances in Drug Therapy for Parkinson's Disease
por: Murakami, Hidetomo, et al.
Publicado: (2022)

10227 A Framework for Bringing Secondary Analysis of EHR Data to Geographically Dispersed Clinician Scientists
por: McClay, James, et al.
Publicado: (2021)

Tremor in Parkinson’s Disease: From Pathophysiology to Advanced Therapies
por: Abusrair, Ali H., et al.
Publicado: (2022)

Genetics of Parkinson’s Disease - A Clinical Perspective
por: Cheon, Sang-Myung, et al.
Publicado: (2012)

Challenges in the clinical advancement of cell therapies for Parkinson’s disease
por: Skidmore, Sophie, et al.
Publicado: (2023)

Bringing microbiome-drug interaction research into the clinic
por: Guthrie, Leah, et al.
Publicado: (2019)

Emerging diabetes therapies: Bringing back the β-cells
por: Basile, G., et al.
Publicado: (2022)

Clinical Advances and Perspectives in Targeted Radionuclide Therapy
por: Lepareur, Nicolas, et al.
Publicado: (2023)

Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
por: Antonini, Angelo
Publicado: (2009)

Clinical aspects of palliative care in advanced Parkinson’s disease
por: Lokk, Johan, et al.
Publicado: (2012)

Cysticercosis Control: Bringing Advances to the Field
por: O’Neal, SE, et al.
Publicado: (2011)

Impact of Infusion Therapies on Quality of Life in Advanced Parkinson’s Disease
por: Constantin, Viorelia A, et al.
Publicado: (2023)

DJ-1 in Parkinson’s Disease: Clinical Insights and Therapeutic Perspectives
por: Repici, Mariaelena, et al.
Publicado: (2019)

The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG)
por: Coghill, David, et al.
Publicado: (2021)

Alzheimer's and Parkinson's disease therapies in the clinic
por: Chopade, Puja, et al.
Publicado: (2022)

Bringing Science to Cancer Therapy
por: Mellman, Ira
Publicado: (2007)

Bringing up Children
Publicado: (1946)

Cannot write session to /tmp/vufind_sessions/sess_pa61jupih785qfosonlad2eb8m